AmeriSource Health Corp and Bergen Brunswig Corp have agreed to merge ina deal that would create the largest wholesale drug distributor in the USA.The merged company, which will be called AmeriSource-Bergen, will generate $35 billion in annual revenues and have a market capitalization of around $4.5 billion.
The new group, which will be 51%-owned by AmeriSource shareholders, will have a 10-member board, with the latter's chief executive, David Yost, holding the same role. His counterpart at Bergen Brunswig, Robert Martini, will become chairman, and he said that the merged company will provide "greater depth of product offerings."
FTC to scupper deal?
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze